Law360, New York (July 21, 2006, 12:00 AM EDT) -- Just days after a federal court issued a Markman ruling in a drawn-out patent battle between Enzo Biochem Inc. and a group of rival biotech companies, Roche Molecular Diagnostics said Friday that the ruling is in its favor, despite Enzo’s earlier claims to the contrary.
Judge John Sprizzo of the U.S. District Court for the Southern District of New York ruled Wednesday on the constructions of 15 disputed claims in the case covering eight different patents.
The patents at issue in the case involve the technology...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.